Although survival analysis suggests that low expression of miR-139-5p also has predictive value for the prognosis of patients with IDH mutant gliomas, it is important to emphasize that IDH1 mutant tumours may have unique metabolic characteristics. This evidence concerns the gene IDH1 and central nervous system cancer.